References
- Ambrosius WT, Sink KM, Foy CG, et al. The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: The Systolic Blood Pressure Intervention Trial (SPRINT). Clinical Trials. 2014;11(5):532–546.
- The SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373:2103–2116.
- Kjeldsen SE, Oparil S, Narkiewicz K, et al. The J-curve phenomenon revisited again: SPRINT outcomes favor target systolic blood pressure below 120 mmHg. Blood Press. 2016;25(1):1–3.
- Burnier M, Oparil S, Narkiewicz K, et al. New 2017 American Heart Association and American College of Cardiology guideline for hypertension in the adults: major paradigm shifts, but will they help to fight against the hypertension disease burden? Blood Press. 2018;27(2):62–65.
- Kjeldsen SE, Narkiewicz K, Burnier M, et al. Intensive blood pressure lowering prevents mild cognitive impairment and possible dementia and slows development of white matter lesions in brain: the SPRINT Memory and Cognition IN Decreased Hypertension (SPRINT MIND) study. Blood Press. 2018;27(5):247–248.
- Williamson JD, Pajewski NM, Auchus AP, et al. Effect of intensive vs. standard blood pressure control on probable dementia. A randomized clinical trial. JAMA. 2019;321:553–561.
- Nasrallah IM, Pajewski NM, Acchus AP, et al. Association of intensive vs standard blood pressure control with cerebral white matter lesions. JAMA. 2019;322:524–534.
- Duning T, Kloska S, Steinsträter O, et al. Dehydration confounds the assessment of brain atrophy. Neurology. 2005;64(3):548–550.
- Williams B, Mancia G, Spiering W, et al. 2018 Practice guidelines for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Blood Press. 2018;27(6):314–340.